GASPERINI, CATERINA
 Distribuzione geografica
Continente #
EU - Europa 252
AS - Asia 67
NA - Nord America 30
SA - Sud America 8
AF - Africa 2
Totale 359
Nazione #
IT - Italia 242
US - Stati Uniti d'America 30
SG - Singapore 28
CN - Cina 17
VN - Vietnam 9
BR - Brasile 4
DE - Germania 4
FR - Francia 3
HK - Hong Kong 3
IN - India 3
AE - Emirati Arabi Uniti 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
GB - Regno Unito 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
MA - Marocco 1
NO - Norvegia 1
NP - Nepal 1
PY - Paraguay 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 359
Città #
Genoa 103
Genova 81
Vado Ligure 31
Rapallo 26
Ashburn 14
Singapore 13
San Jose 5
Council Bluffs 3
Frankfurt am Main 3
Hong Kong 3
Lauterbourg 3
Santa Clara 3
Beijing 2
Da Nang 2
Delhi 2
Ho Chi Minh City 2
Abidjan 1
Ambato 1
Bishkek 1
Biên Hòa 1
Bogotá 1
Boston 1
Bắc Giang 1
Casablanca 1
Ciudad del Este 1
Dubai 1
Huntingdon 1
Hải Dương 1
Ibirubá 1
Jundiaí 1
Kathmandu 1
Leipzig 1
Moscow 1
Pattaya 1
Porto Velho 1
Riyadh 1
Rome 1
Santiago 1
Skien 1
Suwon 1
São Paulo 1
Thrissur 1
Tianjin 1
Tokyo 1
Tukwila 1
Totale 325
Nome #
Role of small noncoding RNAs in mammalian adult neurogenesis 148
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies 83
Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS) 79
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis 50
Treg Susceptibility to Cladribine-Induced Depletion Correlates With Therapy Response in Patients With Multiple Sclerosis 11
Totale 371
Categoria #
all - tutte 1.420
article - articoli 1.025
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 4 1 2
2021/202246 3 2 3 3 2 3 3 5 7 11 0 4
2022/202335 6 2 0 2 3 6 0 3 8 0 5 0
2023/202417 1 2 0 3 1 1 1 4 2 0 0 2
2024/202574 1 3 3 3 17 6 5 9 8 2 10 7
2025/2026154 22 2 7 4 34 15 39 10 12 9 0 0
Totale 371